Marijuana tied to weight loss in new Fed study | Cannabis Sciences – Labroots
✦ New CED Clinical Relevance #68 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchTHCSafetyCannabis SciencesObesityHealth OutcomesMetabolism Clinical Summary A recent study published in The…
LEVEL Sleep Protab Improved Sleep Quality and Next-Morning Outcomes in Independent …
✦ New CED Clinical Relevance #76 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SleepResearchCBDTHCSafetyDosingIndustry Clinical Summary # Clinical Summary A 29-day independent study evaluated…
Cannabis Rescheduling Arrives, With Limits: What The DOJ’s Final Order Does And Doesn’t Do
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchTHCCBDHempIndustrySafety Why This Matters Cannabis rescheduling to Schedule III will enable clinical…
SYT-510 for Generalized Anxiety Disorder: Phase 2 Trial Dosing Initiated | Psychiatric Times
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. AnxietyMental HealthResearchDosingSafetyNeurologyIndustry Why This Matters Clinicians treating generalized anxiety…
Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. AnxietyMental HealthNeurologyResearchSafetyIndustrySleep Why This Matters Clinicians treating generalized anxiety…
Healthy volunteers needed for CBD research – JHU Hub – Johns Hopkins University
✦ New CED Clinical Relevance #78 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDResearchSafetyMental HealthAnxietyHempDosing Why This Matters This Johns Hopkins study will generate clinical…
Cannabidiol Fragile X Trial Fails to Meet Primary Endpoint – Hemp Gazette
Recent cannabidiol fragile x syndrome trial results demonstrate the challenges of translating preclinical cannabis research into effective treatments for neurodevelopmental disorders. This clinical analysis examines what the trial failure means for…
Minnesota Legislature Passes Omnibus Cannabis Bill Restructuring Medical and Adult-Use …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustryResearchHempCBDTHCSafety Clinical Summary # Clinical Summary Minnesota's passage of comprehensive…
Cannabis Pharmaceuticals Business Research Report 2026: An $111.1 Billion Market by …
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. SleepPainAnxietyResearchCBDTHCAging Why This Matters Clinicians need awareness of the expanding cannabis pharmaceutical…
Clinical Trial: Marijuana Oil With THC and CBD May Reduce Pain and Improve Sleep in …
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SleepPainCBDTHCResearchDosingSafety Why This Matters Clinicians need evidence on cannabis dosing and cannabinoid…